Institute of Pediatric Nephrology, Shaare Zedek Medical Center, 12 Shmuel Bait St., 9103102, Jerusalem, Israel.
Imaging Department, Shaare Zedek Medical Center, Jerusalem, Israel.
Pediatr Nephrol. 2021 Oct;36(10):3123-3132. doi: 10.1007/s00467-021-05002-1. Epub 2021 Mar 2.
Systemic oxalosis is a severe complication seen in primary hyperoxaluria type I patients with kidney failure. Deposition of insoluble calcium oxalate crystals in multiple organs leads to significant morbidity and mortality.
We describe a retrospective cohort of 11 patients with systemic oxalosis treated at our dialysis unit from 1982 to 1998 (group 1) and 2007-2019 (group 2). Clinical and demographic data were collected from medical records. Imaging studies were only available for patients in group 2 (n = 5).
Median age at dialysis initiation was 6.1 months (IQR 4-21.6), 64% were male. Dialysis modality was mostly peritoneal dialysis in group 1 and daily hemodialysis in group 2. Bone disease was the first manifestation of systemic oxalosis, starting with the appearance of sclerotic bands (mean 166 days, range 1-235), followed by pathological fractures in long bones (mean 200.4 days, range 173-235 days). Advanced disease was characterized by vertebral fractures with resulting kyphosis, worsening splenomegaly, and adynamic bone disease. Two patients developed pulmonary hypertension, 4 and 8 months prior to their death. Four of 11 patients developed hypothyroidism 0-60 months after dialysis initiation. Only one patient survived after a successful liver-kidney transplantation. Four patients died after liver or liver-kidney transplantation.
This is the first comprehensive description of the natural history of pediatric systemic oxalosis. We hope that our findings will provide basis for a quantitative severity score in future, larger studies.
系统性草酸钙沉着症是一种严重的并发症,见于肾衰竭的原发性高草酸尿症 I 型患者。在多个器官中不可溶性草酸钙晶体的沉积导致显著的发病率和死亡率。
我们描述了 1982 年至 1998 年(第 1 组)和 2007 年至 2019 年(第 2 组)在我们透析单位治疗的 11 例系统性草酸钙沉着症患者的回顾性队列。从病历中收集了临床和人口统计学数据。仅对第 2 组的 5 名患者进行了影像学研究。
开始透析时的中位年龄为 6.1 个月(IQR 4-21.6),64%为男性。第 1 组的透析方式主要是腹膜透析,第 2 组主要是每日血液透析。骨病是系统性草酸钙沉着症的首发表现,开始时出现硬化带(平均 166 天,范围 1-235 天),随后长骨出现病理性骨折(平均 200.4 天,范围 173-235 天)。晚期疾病的特征是椎体骨折导致后凸畸形、脾肿大加重和动力性骨病。2 例患者在死亡前 4 个月和 8 个月分别发展为肺动脉高压。11 例患者中有 4 例在开始透析后 0-60 个月发生甲状腺功能减退。只有 1 例患者在成功进行肝肾移植后存活。4 例患者在肝移植或肝肾移植后死亡。
这是儿科系统性草酸钙沉着症自然史的首次全面描述。我们希望我们的发现将为未来更大规模的研究提供定量严重程度评分的基础。